Literature DB >> 24867465

Defining the outcome of patients with delayed diagnosis of differentiated thyroid cancer.

Moran Amit1, Yaron Rudnicki, Yoav Binenbaum, Leonor Trejo-Leider, Jacob T Cohen, Ziv Gil.   

Abstract

OBJECTIVES/HYPOTHESIS: In the present study we sought to define the outcome of patients with delay in diagnosis and treatment (>1 year) of well-differentiated thyroid carcinoma (WDTC) due to initial benign cytology (IBC). STUDY
DESIGN: Retrospective medical record review and analysis of survival outcomes.
METHODS: The records of 47 patients with delayed diagnosis of thyroid cancer were reviewed. In 38, surgery was performed for growing nodules and in nine due to malignant cytology during follow-up. Median time to delayed surgery was 52 months (range, 13-205 months). Multivariate analysis was performed to assess variables associated with outcome.
RESULTS: Most patients (32/47) underwent total thyroidectomy, whereas 15/47 had hemithyroidectomy. With a median follow-up of 96 months (range, 12-184 months), the 5-year disease-free survival of these patients was 96%. Multivariate analysis showed that the outcome of these patients was not statistically different than that of patients (n = 162) who underwent immediate surgery for similar disease.
CONCLUSIONS: We show that patients with delayed diagnosis and treatment for WDTC due to IBC have excellent outcome. LEVEL OF EVIDENCE: 4.
© 2014 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Thyroid; delayed; fine-needle aspiration; observation; papillary; surgery

Mesh:

Year:  2014        PMID: 24867465     DOI: 10.1002/lary.24744

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

Review 1.  Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies.

Authors:  Mohamed Aashiq; Deborah A Silverman; Shorook Na'ara; Hideaki Takahashi; Moran Amit
Journal:  Cancers (Basel)       Date:  2019-09-17       Impact factor: 6.639

2.  Editorial: Does Every Thyroid Cancer Patient Need Surgery?

Authors:  Ziv Gil; Salem Billan
Journal:  Rambam Maimonides Med J       Date:  2022-04-26

3.  Limited disease progression in endocrine surgery patients with treatment delays due to COVID-19.

Authors:  Reagan A Collins; Catherine DiGennaro; Toni Beninato; Rajshri M Gartland; Natalia Chaves; Jordan M Broekhuis; Lekha Reddy; Jenna Lee; Angelina Deimiller; Maeve M Alterio; Michael J Campbell; Yeon Joo Lee; Tyler K Khilnani; Latoya A Stewart; Mollie A O'Brien; Miguel Valdivia Y Alvarado; Feibi Zheng; David McAneny; Rachel Liou; Catherine McManus; Sophie Y Dream; Tracy S Wang; Tina W Yen; Amal Alhefdhi; Brendan M Finnerty; Thomas J Fahey; Claire E Graves; Amanda M Laird; Matthew A Nehs; Frederick Thurston Drake; James A Lee; Christopher R McHenry; Benjamin C James; Janice L Pasieka; Jennifer H Kuo; Carrie Cunningham Lubitz
Journal:  Surgery       Date:  2022-08-29       Impact factor: 4.348

Review 4.  Framework for prioritizing head and neck surgery during the COVID-19 pandemic.

Authors:  Michael C Topf; Jared A Shenson; F Christopher Holsinger; Samuel H Wald; Lisa J Cianfichi; Eben L Rosenthal; John B Sunwoo
Journal:  Head Neck       Date:  2020-05-06       Impact factor: 3.147

5.  What is Elective Oncologic Surgery in the Time of COVID-19? A Literature Review of the Impact of Surgical Delays on Outcomes in Patients with Cancer.

Authors:  Denise Garcia; Julie B Siegel; David A Mahvi; Biqi Zhang; David M Mahvi; E Ramsay Camp; Whitney Graybill; Stephen J Savage; Antonio Giordano; Sara Giordano; Denise Carneiro-Pla; Mahsa Javid; Aaron P Lesher; Andrea Abbott; Nancy Klauber DeMore
Journal:  Clin Oncol Res       Date:  2020-06-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.